Me. Goldberg et al., Peripheral neuropathy in healthy men volunteers anesthetized with 1.25 MACsevoflurane for 8 hours, PHARMACOTHE, 19(10), 1999, pp. 1173-1176
Two men volunteers developed peripheral neuropathy after prolonged anesthes
ia with 1.25 minimum alveolar concentration sevoflurane at an inflow rate o
f 2 L/minute of fresh gas that caused concurrent administration of relative
ly large doses (ppm-hrs) of the degradation product of sevoflurane, compoun
d A. Other similarly treated volunteers had lesser degrees of transient neu
ropathy. This result does not prove but raises the question of whether comp
ound A or other factors associated with sevoflurane anesthesia can predispo
se patients to peripheral neuropathy.